Skip to main content

Table 2 Published studies of biological reconstruction and megaprosthesis replacement

From: Pedicle frozen autograft–prosthesis composite reconstructions for malignant bone tumors of the proximal femur

Author

Method

Year of publication

Number of patients

MSTS score

Non-union of junction rate

Union time (mon)

follow-up period (year)

5 years Graft Survival(%)

10 years Graft Survival(%)

Infection(%)

Recurrence(%)

Graft Fracture(%)

Loosening

Dislocation

Menendez LR. et al. [4]

Megaprosthesis

2006

96

73%

N/A

N/A

1.5 (0.1–11)

82%

82%

6%

3%

N/A

0%

10%

Zehr RJ. et al. [17]

Megaprosthesis

2003

18

80%

N/A

N/A

9.5(0.3–23)

65%

58%

6%

12%

N/A

6%

6%

Finstein HL.et al. [24]

Megaprosthesis

2007

62

71%

N/A

N/A

5(0.1–22)

79%

57%

5%

7%

N/A

10%

5%

Iyas l. et al. [25]

Megaprosthesis

2002

15

63%

N/A

N/A

6.7(3–10)

Not report

Not report

13%

7%

N/A

7%

20%

Dubory A. et al. [16]

APC

2017

30

77%

16%

Not report

14.7(6.3–32.6)

73.00%

54%

4%

7%

13%

4%

9%

Lanlais F.et al. [5]

APC

2003

21

77%

11%

Not report

5.7(0.25–15)

90%

81%

0%

29%

0%

14%

0%

Muscolo DL. et al. [18]

APC

2010

38

90%

7%

Not report

7.5(3–17)

72%

69%

7%

3%

18%

0%

0%

Biau DJ. et al. [6]

APC

2010

32

Not report

19%

Not report

5.7(0.2–19.3)

86%

81%

13%

9%

3%

6%

3%

Chen CF. et al. [20]

Irradiation

2009

14

72%

8%

20 (14–40)

5.6 (1.5–9.75)

85%

Not report

0%

0%

0%

0%

0%

Eid AS. et al. [19]

Pasteurization

2011

18

80%

5%

13(6~18)

7.75(1.17–13.6)

86%

86%

11%

16%

0%

6%

6%

Current study

FAPC

 

19

87.60%

N/A

N/A

5.2 (0.67–15)

100%

50%

5%

5%

5%

0%

5%

  1. APC allograft-prosthesis composite, FAPC frozen autograft-prosthesis composite, N/A not available